TABLE 1.
Drug name | Potency: PDE5i | Potency: other actions | References |
---|---|---|---|
Sildenafil | 1–9 nM | PDE6: 10–40 nM | 8 , 25 , 26 , 27 , 28 |
KD 3.1 nM | |||
Tadalafil | 1–7 nM |
PDE6: Ki 700 Nm PDE11: 10—300 nM |
8 , 25 , 26 , 27 , 29 , 30 |
KD 1.7 nM | |||
Ki 1.9 nM | |||
Vardenafil | 0.1‐1.0 nM | PDE1: 300 nM | 8 , 25 , 26 , 29 |
KD 0.32 nM | PDE6: Ki 0.3‐11 nM | ||
Ki 2.3 nM | PDE9: 680 nM | ||
PDE11: 240 nM | |||
Udenafil | 6–8 nM | PDE 1: 870 nM | 31 |
PDE 6: 50 nM | |||
Dipyridamole | 900–2000 nM | PDE6: 380–1000 nM | 27 , 28 , 30 |
PDE7: 1–2 μM | |||
PDE10: 1 μM | |||
PDE11: 800 nM | |||
Zaprinast | 50 nM–2.5 μM a | PDE6: 150 nM | 27 , 28 |
Wide species and tissue dependence of zaprinast potency as a PDE5i.
Abbreviation: PDE, phosphodiesterase; PDE5i, phosphodiesterase‐5 inhibitor.